World's Best Scientists 2026 revealed!
David H. Harpole

David H. Harpole

D-Index & Metrics

Medicine

D-Index
79
Citations
24078
World Ranking
17512
National Ranking
8764

Overview

David H. Harpole is affiliated with Duke University in the United States. Their research primarily focuses on medicine, with a significant emphasis on pulmonary and respiratory medicine, surgery, oncology, radiology, nuclear medicine and imaging, as well as cardiology and cardiovascular medicine.

Their work covers several main topics including lung cancer diagnosis and treatment, lung cancer treatments and mutations, esophageal cancer research and treatment, gastric cancer management and outcomes, esophageal and gastrointestinal pathology, cancer immunotherapy and biomarkers, and lung cancer research studies.

Notable recent publications by David H. Harpole include:

  • Perioperative Durvalumab for Resectable Non-Small-Cell Lung Cancer, 2023, New England Journal of Medicine
  • Perioperative outcomes of pulmonary resection after neoadjuvant pembrolizumab in patients with non-small cell lung cancer, 2021, Journal of Thoracic and Cardiovascular Surgery
  • Design and Rationale for a Phase III, Double-Blind, Placebo-Controlled Study of Neoadjuvant Durvalumab + Chemotherapy Followed by Adjuvant Durvalumab for the Treatment of Patients With Resectable Stages II and III non-small-cell Lung Cancer: The AEGEAN Trial, 2021, Clinical Lung Cancer
  • Abstract CT005: AEGEAN: A phase 3 trial of neoadjuvant durvalumab + chemotherapy followed by adjuvant durvalumab in patients with resectable NSCLC, 2023, Cancer Research
  • Stellate Ganglion Blockade for the Treatment of Refractory Ventricular Arrhythmias, 2020, JACC. Clinical electrophysiology

David H. Harpole frequently collaborates with several researchers, including Betty C. Tong, Thomas A. D'Amico, Vignesh Raman, Oliver K. Jawitz, and John V. Heymach.

Their findings are often published in prominent venues such as the Journal of Thoracic Oncology, Journal of Thoracic and Cardiovascular Surgery, The Annals of Thoracic Surgery, Annals of Surgery, and Journal of Clinical Oncology.

Best Publications

  • Oncogenic pathway signatures in human cancers as a guide to targeted therapies.

    Andrea H. Bild;Guang Yao;Jeffrey T. Chang;Quanli Wang

  • Adjuvant Paclitaxel Plus Carboplatin Compared With Observation in Stage IB Non–Small-Cell Lung Cancer: CALGB 9633 With the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups

    Gary M. Strauss;James E. Herndon;Michael A. Maddaus;David W. Johnstone

  • Thoracoscopic lobectomy is associated with lower morbidity than open lobectomy: A propensity-matched analysis from the STS database

    Subroto Paul;Nasser K. Altorki;Shubin Sheng;Paul C. Lee

  • Morbidity and Mortality of Major Pulmonary Resections in Patients With Early-Stage Lung Cancer: Initial Results of the Randomized, Prospective ACOSOG Z0030 Trial

    Mark S. Allen;Gail E. Darling;Taine T.V. Pechet;John D. Mitchell

  • Retraction: Genomic signatures to guide the use of chemotherapeutics

    Anil Potti;Holly K Dressman;Andrea Bild;Richard F Riedel

  • A genomic strategy to refine prognosis in early-stage non-small-cell lung cancer.

    Anil Potti;Sayan Mukherjee;Rebecca Petersen;Holly K. Dressman

  • Data from The Society of Thoracic Surgeons General Thoracic Surgery database: The surgical management of primary lung tumors

    Daniel J. Boffa;Mark S. Allen;Joshua D. Grab;Henning A. Gaissert

  • Tumor infiltrating Foxp3+ regulatory T‐cells are associated with recurrence in pathologic stage I NSCLC patients

    Rebecca P. Petersen;Michael J. Campa;Justin Sperlazza;Debbi Conlon

  • Outcomes after esophagectomy: a ten-year prospective cohort

    Stephen H Bailey;David A Bull;David H Harpole;Jeffrey J Rentz

  • Reducing hospital morbidity and mortality following esophagectomy

    B.Zane Atkins;Ashish S. Shah;Kelley A. Hutcheson;Jennifer H. Mangum

  • A DLL3-targeted antibody-drug conjugate eradicates high-grade pulmonary neuroendocrine tumor-initiating cells in vivo

    Laura R. Saunders;Alexander J. Bankovich;Wade C. Anderson;Monette A. Aujay

  • Thoracoscopic Lobectomy Is a Safe and Versatile Procedure: Experience With 500 Consecutive Patients

    Mark W. Onaitis;Rebecca P. Petersen;Stafford S. Balderson;Eric Toloza

  • Thoracoscopic lobectomy is associated with lower morbidity compared with thoracotomy.

    Nestor R. Villamizar;Marcus D. Darrabie;William R. Burfeind;Rebecca P. Petersen

  • Hypermethylated APC DNA in Plasma and Prognosis of Patients With Esophageal Adenocarcinoma

    Kazuyuki Kawakami;Jan Brabender;Reginald V. Lord;Susan Groshen

  • A Prognostic Model of Recurrence and Death in Stage I Non-Small Cell Lung Cancer Utilizing Presentation, Histopathology, and Oncoprotein Expression

    Harpole Dh;Herndon Je nd;Wolfe Wg;Iglehart Jd

  • Prognostic models of thirty-day mortality and morbidity after major pulmonary resection.

    David H. Harpole;Malcolm M. DeCamp;Jennifer Daley;Kwan Hur

  • Thoracoscopic Lobectomy Facilitates the Delivery of Chemotherapy after Resection for Lung Cancer

    Rebecca P. Petersen;Duy Khanh Pham;William R. Burfeind;Steven I. Hanish

  • Results of the American College of Surgeons Oncology Group Z0050 trial: the utility of positron emission tomography in staging potentially operable non–small cell lung cancer

    Carolyn E Reed;David H Harpole;Katherine E Posther;Sandra L Woolson

  • Predictive value of the EphA2 receptor tyrosine kinase in lung cancer recurrence and survival.

    Michael S. Kinch;Mary-Beth Moore;David H. Harpole

  • A biologic risk model for stage I lung cancer: Immunohistochemical analysis of 408 patients with the use of ten molecular markers

    Thomas A. D'Amico;Marga Massey;James E. Herndon Ii;Mary-Beth Moore

Frequent Co-Authors

Thomas A. D'Amico
Thomas A. D'Amico Duke University
James E. Herndon
James E. Herndon Duke University
David J. Sugarbaker
David J. Sugarbaker Baylor College of Medicine
Raphael Bueno
Raphael Bueno Brigham and Women's Hospital
Joseph R. Nevins
Joseph R. Nevins Duke University
William G. Richards
William G. Richards Brigham and Women's Hospital
Karla V. Ballman
Karla V. Ballman Cornell University
Jeffrey R. Marks
Jeffrey R. Marks Duke University
Andrew Berchuck
Andrew Berchuck Duke University
Valerie W. Rusch
Valerie W. Rusch Memorial Sloan Kettering Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Interested in the broader field of healthcare or seeking alternative routes into medical careers? There are several flexible online programs that can kickstart or advance your journey. For those passionate about nutrition and patient wellness, an online BS in nutrition provides foundational science knowledge and prepares you for roles in public health, counseling, or food science.

If your goal is to move into healthcare leadership, consider pursuing one of the CAHME-accredited Master of Healthcare Administration (MHA) programs online. These programs are recognized for quality and can open doors to management positions in hospitals, clinics, and health systems.

Registered Nurses aiming to advance their careers may opt for RN BSN online programs no clinicals, which allow you to earn your BSN with minimal on-site requirements—ideal for working professionals.

Lastly, those wishing to reach the highest clinical level can explore accelerated MSN to DNP programs. These rigorous online paths help nurses gain advanced practice skills in less time.

Best Scientists Citing David H. Harpole

Trending Scientists